Table 2.

Univariate and multivariate analysis of factors related with recurrence free survival in training set.

	HR	P	95% CI	HR	P	95% CI
Age (>60)	0.945	0.653	0.738–1.210
Gender	1.319	0.079	0.968–1.799
Positive HBsAg	1.188	0.329	0.841–1.680
Positive HBeAg	1.386	0.021	1.049–1.830	1.420	0.015	1.070–1.884
Positive HBcAb	0.893	0.767	0.422–1.889
Liver cirrhosis	1.220	0.091	0.965–1.537
Child-Pugh	1.172	0.323	0.856–1.603
Tumor size	1.080	<0.001	1.046–1.116
Tumor number	1.800	<0.001	1.494–2.168	1.564	<0.001	1.287–1.901
MVI	1.826	<0.001	1.443–2.311	1.562	0.001	1.285–2.096
Satellite lesions	2.550	<0.001	1.835–3.544	1.817	0.001	1.290–2.560
Differentiation	1.253	0.044	1.006–1.560
AFP (>400 ng/ml)	1.272	0.032	1.021–1.585
TBIL	1.003	0.740	0.986–1.019
ALT	1.001	0.294	0.999–1.003
AST	1.003	0.050	1.000–1.007
CREA	1.004	0.237	0.998–1.010
INR	1.546	0.435	0.518–4.608
Fibrinogen	1.093	0.132	0.973–1.228
PLR (>167.7)	1.737	0.001	1.243–2.427	1.569	0.009	1.118–2.202
NLR (>3.1)	1.484	0.002	1.162–1.895
AGR (>0.5)	0.540	<0.001	0.433–0.674	0.696	0.002	0.551–0.879

HR, hazard ratio; CI, confidence interval. The bold indicates statistically significant.